Pharmacotherapy
February 2024
Study Objective: The purpose of this study is to provide evidence for the safety and efficacy of factor Xa inhibitors in patients with a weight ≤60 kg or BMI < 18.5 kg/m .Design: Multicenter, retrospective, cohort study.
© LitMetric 2025. All rights reserved.